TRH testing versus ultrasensitive basal TSH measurement in thyroid cancer patients under suppressive thyroxine therapy.

被引：0
|
作者：
Görges, R [1 ]
Saller, B [1 ]
Muller, SP [1 ]
Brandt-Mainz, K [1 ]
Mann, K [1 ]
Bockisch, A [1 ]
机构：
[1] Univ Essen Gesamthsch, Essen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1999年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
923
引用
收藏
页码：206P / 206P
页数：1
相关论文
共 28 条
  • [1] ULTRASENSITIVE TSH ASSAY AFTER TRH INJECTION IN THYROID-CANCER PATIENTS UNDER SUPPRESSIVE TREATMENT
    HESHMATI, HM
    IZEMBART, M
    DAGOUSSET, F
    NASSER, H
    VALLEE, G
    [J]. SEMAINE DES HOPITAUX, 1991, 67 (03): : 55 - 58
  • [2] Surveillance of TSH-suppressive levothyroxine treatment in thyroid cancer patients:: TRH testing versus basal TSH determination by a third generation assay
    Görges, R
    Saller, B
    Eising, EG
    Quadbeck, B
    Mann, K
    Bockisch, A
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2002, 110 (07) : 355 - 360
  • [3] ULTRASENSITIVE TSH DETERMINATION AFTER TRH INJECTION IN OPERATED THYROID-CANCER UNDER SUPPRESSIVE TREATMENT
    HESHMATI, HM
    IZEMBART, M
    DAGOUSSET, F
    NASSER, H
    VALLEE, G
    [J]. HORMONE RESEARCH, 1987, 26 (1-4) : 214 - 215
  • [4] SUPPRESSION OF THE TSH RESPONSE TO TRH BY THYROXINE THERAPY IN DIFFERENTIATED THYROID-CARCINOMA PATIENTS
    LAMBERG, BA
    RANTANEN, M
    SAARINEN, P
    LIEWENDAHL, K
    SIVULA, A
    [J]. ACTA ENDOCRINOLOGICA, 1979, 91 (02): : 248 - 256
  • [5] Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?
    Graham R. Williams
    [J]. Journal of Endocrinological Investigation, 2014, 37 : 775 - 779
  • [6] Is prophylactic anti-resorptive therapy required in thyroid cancer patients receiving TSH-suppressive treatment with thyroxine?
    Williams, Graham R.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2014, 37 (08): : 775 - 779
  • [7] Comparison of radioimmunoassay and chemiluminescence immunoassay in measuring thyroid hormone levels in athyroid patients with and without thyroxine suppressive therapy.
    Huang, WS
    Kuo, SW
    Liao, YC
    Chung, ML
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 271P - 271P
  • [8] Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy
    Toivonen, J
    Tahtela, R
    Laitinen, K
    Risteli, J
    Valimaki, MJ
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (06) : 667 - 673
  • [9] HIGHLY SENSITIVE DETERMINATION OF TSH IN THE FOLLOW-UP OF TSH-SUPPRESSIVE THERAPY OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER
    MANN, K
    SALLER, B
    MEHL, U
    HORMANN, R
    MOSER, E
    [J]. NUKLEARMEDIZIN, 1988, 27 (01) : 24 - 28
  • [10] CHRONIC SUPPRESSIVE THYROXINE THERAPY AND FOREARM, SPINAL AND HOP BONE-DENSITY IN 114 PATIENTS WITH THYROID-CANCER
    HAWKINS, F
    LOPEZ, MB
    RIGOPOULOU, D
    PAPAPIETRO, K
    GARCIA, L
    SARABIA, F
    ARNAIZ, F
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S252 - S252
123